1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global PPARδ Agonist Annual Sales 2020-2031 2.1.2 World Current & Future Analysis for PPARδ Agonist by Geographic Region, 2020, 2024 & 2031 2.1.3 World Current & Future Analysis for PPARδ Agonist by Country/Region, 2020, 2024 & 2031 2.2 PPARδ Agonist Segment by Type 2.2.1 GW0742 2.2.2 Lanifibranor 2.2.3 Elafibranor 2.3 PPARδ Agonist Sales by Type 2.3.1 Global PPARδ Agonist Sales Market Share by Type (2020-2025) 2.3.2 Global PPARδ Agonist Revenue and Market Share by Type (2020-2025) 2.3.3 Global PPARδ Agonist Sale Price by Type (2020-2025) 2.4 PPARδ Agonist Segment by Application 2.4.1 Cirrhosis 2.4.2 Nonalcoholic Steatohepatitis 2.4.3 Diabetes 2.4.4 Reduce Inflammation 2.4.5 Others 2.5 PPARδ Agonist Sales by Application 2.5.1 Global PPARδ Agonist Sale Market Share by Application (2020-2025) 2.5.2 Global PPARδ Agonist Revenue and Market Share by Application (2020-2025) 2.5.3 Global PPARδ Agonist Sale Price by Application (2020-2025) 3 Global by Company 3.1 Global PPARδ Agonist Breakdown Data by Company 3.1.1 Global PPARδ Agonist Annual Sales by Company (2020-2025) 3.1.2 Global PPARδ Agonist Sales Market Share by Company (2020-2025) 3.2 Global PPARδ Agonist Annual Revenue by Company (2020-2025) 3.2.1 Global PPARδ Agonist Revenue by Company (2020-2025) 3.2.2 Global PPARδ Agonist Revenue Market Share by Company (2020-2025) 3.3 Global PPARδ Agonist Sale Price by Company 3.4 Key Manufacturers PPARδ Agonist Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers PPARδ Agonist Product Location Distribution 3.4.2 Players PPARδ Agonist Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) 3.6 New Products and Potential Entrants 3.7 Market M&A Activity & Strategy 4 World Historic Review for PPARδ Agonist by Geographic Region 4.1 World Historic PPARδ Agonist Market Size by Geographic Region (2020-2025) 4.1.1 Global PPARδ Agonist Annual Sales by Geographic Region (2020-2025) 4.1.2 Global PPARδ Agonist Annual Revenue by Geographic Region (2020-2025) 4.2 World Historic PPARδ Agonist Market Size by Country/Region (2020-2025) 4.2.1 Global PPARδ Agonist Annual Sales by Country/Region (2020-2025) 4.2.2 Global PPARδ Agonist Annual Revenue by Country/Region (2020-2025) 4.3 Americas PPARδ Agonist Sales Growth 4.4 APAC PPARδ Agonist Sales Growth 4.5 Europe PPARδ Agonist Sales Growth 4.6 Middle East & Africa PPARδ Agonist Sales Growth 5 Americas 5.1 Americas PPARδ Agonist Sales by Country 5.1.1 Americas PPARδ Agonist Sales by Country (2020-2025) 5.1.2 Americas PPARδ Agonist Revenue by Country (2020-2025) 5.2 Americas PPARδ Agonist Sales by Type (2020-2025) 5.3 Americas PPARδ Agonist Sales by Application (2020-2025) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC PPARδ Agonist Sales by Region 6.1.1 APAC PPARδ Agonist Sales by Region (2020-2025) 6.1.2 APAC PPARδ Agonist Revenue by Region (2020-2025) 6.2 APAC PPARδ Agonist Sales by Type (2020-2025) 6.3 APAC PPARδ Agonist Sales by Application (2020-2025) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe PPARδ Agonist by Country 7.1.1 Europe PPARδ Agonist Sales by Country (2020-2025) 7.1.2 Europe PPARδ Agonist Revenue by Country (2020-2025) 7.2 Europe PPARδ Agonist Sales by Type (2020-2025) 7.3 Europe PPARδ Agonist Sales by Application (2020-2025) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa PPARδ Agonist by Country 8.1.1 Middle East & Africa PPARδ Agonist Sales by Country (2020-2025) 8.1.2 Middle East & Africa PPARδ Agonist Revenue by Country (2020-2025) 8.2 Middle East & Africa PPARδ Agonist Sales by Type (2020-2025) 8.3 Middle East & Africa PPARδ Agonist Sales by Application (2020-2025) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of PPARδ Agonist 10.3 Manufacturing Process Analysis of PPARδ Agonist 10.4 Industry Chain Structure of PPARδ Agonist 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 PPARδ Agonist Distributors 11.3 PPARδ Agonist Customer 12 World Forecast Review for PPARδ Agonist by Geographic Region 12.1 Global PPARδ Agonist Market Size Forecast by Region 12.1.1 Global PPARδ Agonist Forecast by Region (2026-2031) 12.1.2 Global PPARδ Agonist Annual Revenue Forecast by Region (2026-2031) 12.2 Americas Forecast by Country (2026-2031) 12.3 APAC Forecast by Region (2026-2031) 12.4 Europe Forecast by Country (2026-2031) 12.5 Middle East & Africa Forecast by Country (2026-2031) 12.6 Global PPARδ Agonist Forecast by Type (2026-2031) 12.7 Global PPARδ Agonist Forecast by Application (2026-2031) 13 Key Players Analysis 13.1 AbMole 13.1.1 AbMole Company Information 13.1.2 AbMole PPARδ Agonist Product Portfolios and Specifications 13.1.3 AbMole PPARδ Agonist Sales, Revenue, Price and Gross Margin (2020-2025) 13.1.4 AbMole Main Business Overview 13.1.5 AbMole Latest Developments 13.2 Delta Bio 13.2.1 Delta Bio Company Information 13.2.2 Delta Bio PPARδ Agonist Product Portfolios and Specifications 13.2.3 Delta Bio PPARδ Agonist Sales, Revenue, Price and Gross Margin (2020-2025) 13.2.4 Delta Bio Main Business Overview 13.2.5 Delta Bio Latest Developments 13.3 Inventiva 13.3.1 Inventiva Company Information 13.3.2 Inventiva PPARδ Agonist Product Portfolios and Specifications 13.3.3 Inventiva PPARδ Agonist Sales, Revenue, Price and Gross Margin (2020-2025) 13.3.4 Inventiva Main Business Overview 13.3.5 Inventiva Latest Developments 13.4 RECHEM 13.4.1 RECHEM Company Information 13.4.2 RECHEM PPARδ Agonist Product Portfolios and Specifications 13.4.3 RECHEM PPARδ Agonist Sales, Revenue, Price and Gross Margin (2020-2025) 13.4.4 RECHEM Main Business Overview 13.4.5 RECHEM Latest Developments 13.5 DMK 13.5.1 DMK Company Information 13.5.2 DMK PPARδ Agonist Product Portfolios and Specifications 13.5.3 DMK PPARδ Agonist Sales, Revenue, Price and Gross Margin (2020-2025) 13.5.4 DMK Main Business Overview 13.5.5 DMK Latest Developments 14 Research Findings and Conclusion
List of Tables Table 1. PPARδ Agonist Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions) Table 2. PPARδ Agonist Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions) Table 3. Major Players of GW0742 Table 4. Major Players of Lanifibranor Table 5. Major Players of Elafibranor Table 6. Global PPARδ Agonist Sales by Type (2020-2025) & (K Units) Table 7. Global PPARδ Agonist Sales Market Share by Type (2020-2025) Table 8. Global PPARδ Agonist Revenue by Type (2020-2025) & ($ million) Table 9. Global PPARδ Agonist Revenue Market Share by Type (2020-2025) Table 10. Global PPARδ Agonist Sale Price by Type (2020-2025) & (US$/Unit) Table 11. Global PPARδ Agonist Sale by Application (2020-2025) & (K Units) Table 12. Global PPARδ Agonist Sale Market Share by Application (2020-2025) Table 13. Global PPARδ Agonist Revenue by Application (2020-2025) & ($ million) Table 14. Global PPARδ Agonist Revenue Market Share by Application (2020-2025) Table 15. Global PPARδ Agonist Sale Price by Application (2020-2025) & (US$/Unit) Table 16. Global PPARδ Agonist Sales by Company (2020-2025) & (K Units) Table 17. Global PPARδ Agonist Sales Market Share by Company (2020-2025) Table 18. Global PPARδ Agonist Revenue by Company (2020-2025) & ($ millions) Table 19. Global PPARδ Agonist Revenue Market Share by Company (2020-2025) Table 20. Global PPARδ Agonist Sale Price by Company (2020-2025) & (US$/Unit) Table 21. Key Manufacturers PPARδ Agonist Producing Area Distribution and Sales Area Table 22. Players PPARδ Agonist Products Offered Table 23. PPARδ Agonist Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) Table 24. New Products and Potential Entrants Table 25. Market M&A Activity & Strategy Table 26. Global PPARδ Agonist Sales by Geographic Region (2020-2025) & (K Units) Table 27. Global PPARδ Agonist Sales Market Share Geographic Region (2020-2025) Table 28. Global PPARδ Agonist Revenue by Geographic Region (2020-2025) & ($ millions) Table 29. Global PPARδ Agonist Revenue Market Share by Geographic Region (2020-2025) Table 30. Global PPARδ Agonist Sales by Country/Region (2020-2025) & (K Units) Table 31. Global PPARδ Agonist Sales Market Share by Country/Region (2020-2025) Table 32. Global PPARδ Agonist Revenue by Country/Region (2020-2025) & ($ millions) Table 33. Global PPARδ Agonist Revenue Market Share by Country/Region (2020-2025) Table 34. Americas PPARδ Agonist Sales by Country (2020-2025) & (K Units) Table 35. Americas PPARδ Agonist Sales Market Share by Country (2020-2025) Table 36. Americas PPARδ Agonist Revenue by Country (2020-2025) & ($ millions) Table 37. Americas PPARδ Agonist Sales by Type (2020-2025) & (K Units) Table 38. Americas PPARδ Agonist Sales by Application (2020-2025) & (K Units) Table 39. APAC PPARδ Agonist Sales by Region (2020-2025) & (K Units) Table 40. APAC PPARδ Agonist Sales Market Share by Region (2020-2025) Table 41. APAC PPARδ Agonist Revenue by Region (2020-2025) & ($ millions) Table 42. APAC PPARδ Agonist Sales by Type (2020-2025) & (K Units) Table 43. APAC PPARδ Agonist Sales by Application (2020-2025) & (K Units) Table 44. Europe PPARδ Agonist Sales by Country (2020-2025) & (K Units) Table 45. Europe PPARδ Agonist Revenue by Country (2020-2025) & ($ millions) Table 46. Europe PPARδ Agonist Sales by Type (2020-2025) & (K Units) Table 47. Europe PPARδ Agonist Sales by Application (2020-2025) & (K Units) Table 48. Middle East & Africa PPARδ Agonist Sales by Country (2020-2025) & (K Units) Table 49. Middle East & Africa PPARδ Agonist Revenue Market Share by Country (2020-2025) Table 50. Middle East & Africa PPARδ Agonist Sales by Type (2020-2025) & (K Units) Table 51. Middle East & Africa PPARδ Agonist Sales by Application (2020-2025) & (K Units) Table 52. Key Market Drivers & Growth Opportunities of PPARδ Agonist Table 53. Key Market Challenges & Risks of PPARδ Agonist Table 54. Key Industry Trends of PPARδ Agonist Table 55. PPARδ Agonist Raw Material Table 56. Key Suppliers of Raw Materials Table 57. PPARδ Agonist Distributors List Table 58. PPARδ Agonist Customer List Table 59. Global PPARδ Agonist Sales Forecast by Region (2026-2031) & (K Units) Table 60. Global PPARδ Agonist Revenue Forecast by Region (2026-2031) & ($ millions) Table 61. Americas PPARδ Agonist Sales Forecast by Country (2026-2031) & (K Units) Table 62. Americas PPARδ Agonist Annual Revenue Forecast by Country (2026-2031) & ($ millions) Table 63. APAC PPARδ Agonist Sales Forecast by Region (2026-2031) & (K Units) Table 64. APAC PPARδ Agonist Annual Revenue Forecast by Region (2026-2031) & ($ millions) Table 65. Europe PPARδ Agonist Sales Forecast by Country (2026-2031) & (K Units) Table 66. Europe PPARδ Agonist Revenue Forecast by Country (2026-2031) & ($ millions) Table 67. Middle East & Africa PPARδ Agonist Sales Forecast by Country (2026-2031) & (K Units) Table 68. Middle East & Africa PPARδ Agonist Revenue Forecast by Country (2026-2031) & ($ millions) Table 69. Global PPARδ Agonist Sales Forecast by Type (2026-2031) & (K Units) Table 70. Global PPARδ Agonist Revenue Forecast by Type (2026-2031) & ($ millions) Table 71. Global PPARδ Agonist Sales Forecast by Application (2026-2031) & (K Units) Table 72. Global PPARδ Agonist Revenue Forecast by Application (2026-2031) & ($ millions) Table 73. AbMole Basic Information, PPARδ Agonist Manufacturing Base, Sales Area and Its Competitors Table 74. AbMole PPARδ Agonist Product Portfolios and Specifications Table 75. AbMole PPARδ Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025) Table 76. AbMole Main Business Table 77. AbMole Latest Developments Table 78. Delta Bio Basic Information, PPARδ Agonist Manufacturing Base, Sales Area and Its Competitors Table 79. Delta Bio PPARδ Agonist Product Portfolios and Specifications Table 80. Delta Bio PPARδ Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025) Table 81. Delta Bio Main Business Table 82. Delta Bio Latest Developments Table 83. Inventiva Basic Information, PPARδ Agonist Manufacturing Base, Sales Area and Its Competitors Table 84. Inventiva PPARδ Agonist Product Portfolios and Specifications Table 85. Inventiva PPARδ Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025) Table 86. Inventiva Main Business Table 87. Inventiva Latest Developments Table 88. RECHEM Basic Information, PPARδ Agonist Manufacturing Base, Sales Area and Its Competitors Table 89. RECHEM PPARδ Agonist Product Portfolios and Specifications Table 90. RECHEM PPARδ Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025) Table 91. RECHEM Main Business Table 92. RECHEM Latest Developments Table 93. DMK Basic Information, PPARδ Agonist Manufacturing Base, Sales Area and Its Competitors Table 94. DMK PPARδ Agonist Product Portfolios and Specifications Table 95. DMK PPARδ Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025) Table 96. DMK Main Business Table 97. DMK Latest Developments List of Figures Figure 1. Picture of PPARδ Agonist Figure 2. PPARδ Agonist Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global PPARδ Agonist Sales Growth Rate 2020-2031 (K Units) Figure 7. Global PPARδ Agonist Revenue Growth Rate 2020-2031 ($ millions) Figure 8. PPARδ Agonist Sales by Geographic Region (2020, 2024 & 2031) & ($ millions) Figure 9. PPARδ Agonist Sales Market Share by Country/Region (2024) Figure 10. PPARδ Agonist Sales Market Share by Country/Region (2020, 2024 & 2031) Figure 11. Product Picture of GW0742 Figure 12. Product Picture of Lanifibranor Figure 13. Product Picture of Elafibranor Figure 14. Global PPARδ Agonist Sales Market Share by Type in 2025 Figure 15. Global PPARδ Agonist Revenue Market Share by Type (2020-2025) Figure 16. PPARδ Agonist Consumed in Cirrhosis Figure 17. Global PPARδ Agonist Market: Cirrhosis (2020-2025) & (K Units) Figure 18. PPARδ Agonist Consumed in Nonalcoholic Steatohepatitis Figure 19. Global PPARδ Agonist Market: Nonalcoholic Steatohepatitis (2020-2025) & (K Units) Figure 20. PPARδ Agonist Consumed in Diabetes Figure 21. Global PPARδ Agonist Market: Diabetes (2020-2025) & (K Units) Figure 22. PPARδ Agonist Consumed in Reduce Inflammation Figure 23. Global PPARδ Agonist Market: Reduce Inflammation (2020-2025) & (K Units) Figure 24. PPARδ Agonist Consumed in Others Figure 25. Global PPARδ Agonist Market: Others (2020-2025) & (K Units) Figure 26. Global PPARδ Agonist Sale Market Share by Application (2024) Figure 27. Global PPARδ Agonist Revenue Market Share by Application in 2025 Figure 28. PPARδ Agonist Sales by Company in 2025 (K Units) Figure 29. Global PPARδ Agonist Sales Market Share by Company in 2025 Figure 30. PPARδ Agonist Revenue by Company in 2025 ($ millions) Figure 31. Global PPARδ Agonist Revenue Market Share by Company in 2025 Figure 32. Global PPARδ Agonist Sales Market Share by Geographic Region (2020-2025) Figure 33. Global PPARδ Agonist Revenue Market Share by Geographic Region in 2025 Figure 34. Americas PPARδ Agonist Sales 2020-2025 (K Units) Figure 35. Americas PPARδ Agonist Revenue 2020-2025 ($ millions) Figure 36. APAC PPARδ Agonist Sales 2020-2025 (K Units) Figure 37. APAC PPARδ Agonist Revenue 2020-2025 ($ millions) Figure 38. Europe PPARδ Agonist Sales 2020-2025 (K Units) Figure 39. Europe PPARδ Agonist Revenue 2020-2025 ($ millions) Figure 40. Middle East & Africa PPARδ Agonist Sales 2020-2025 (K Units) Figure 41. Middle East & Africa PPARδ Agonist Revenue 2020-2025 ($ millions) Figure 42. Americas PPARδ Agonist Sales Market Share by Country in 2025 Figure 43. Americas PPARδ Agonist Revenue Market Share by Country (2020-2025) Figure 44. Americas PPARδ Agonist Sales Market Share by Type (2020-2025) Figure 45. Americas PPARδ Agonist Sales Market Share by Application (2020-2025) Figure 46. United States PPARδ Agonist Revenue Growth 2020-2025 ($ millions) Figure 47. Canada PPARδ Agonist Revenue Growth 2020-2025 ($ millions) Figure 48. Mexico PPARδ Agonist Revenue Growth 2020-2025 ($ millions) Figure 49. Brazil PPARδ Agonist Revenue Growth 2020-2025 ($ millions) Figure 50. APAC PPARδ Agonist Sales Market Share by Region in 2025 Figure 51. APAC PPARδ Agonist Revenue Market Share by Region (2020-2025) Figure 52. APAC PPARδ Agonist Sales Market Share by Type (2020-2025) Figure 53. APAC PPARδ Agonist Sales Market Share by Application (2020-2025) Figure 54. China PPARδ Agonist Revenue Growth 2020-2025 ($ millions) Figure 55. Japan PPARδ Agonist Revenue Growth 2020-2025 ($ millions) Figure 56. South Korea PPARδ Agonist Revenue Growth 2020-2025 ($ millions) Figure 57. Southeast Asia PPARδ Agonist Revenue Growth 2020-2025 ($ millions) Figure 58. India PPARδ Agonist Revenue Growth 2020-2025 ($ millions) Figure 59. Australia PPARδ Agonist Revenue Growth 2020-2025 ($ millions) Figure 60. China Taiwan PPARδ Agonist Revenue Growth 2020-2025 ($ millions) Figure 61. Europe PPARδ Agonist Sales Market Share by Country in 2025 Figure 62. Europe PPARδ Agonist Revenue Market Share by Country (2020-2025) Figure 63. Europe PPARδ Agonist Sales Market Share by Type (2020-2025) Figure 64. Europe PPARδ Agonist Sales Market Share by Application (2020-2025) Figure 65. Germany PPARδ Agonist Revenue Growth 2020-2025 ($ millions) Figure 66. France PPARδ Agonist Revenue Growth 2020-2025 ($ millions) Figure 67. UK PPARδ Agonist Revenue Growth 2020-2025 ($ millions) Figure 68. Italy PPARδ Agonist Revenue Growth 2020-2025 ($ millions) Figure 69. Russia PPARδ Agonist Revenue Growth 2020-2025 ($ millions) Figure 70. Middle East & Africa PPARδ Agonist Sales Market Share by Country (2020-2025) Figure 71. Middle East & Africa PPARδ Agonist Sales Market Share by Type (2020-2025) Figure 72. Middle East & Africa PPARδ Agonist Sales Market Share by Application (2020-2025) Figure 73. Egypt PPARδ Agonist Revenue Growth 2020-2025 ($ millions) Figure 74. South Africa PPARδ Agonist Revenue Growth 2020-2025 ($ millions) Figure 75. Israel PPARδ Agonist Revenue Growth 2020-2025 ($ millions) Figure 76. Turkey PPARδ Agonist Revenue Growth 2020-2025 ($ millions) Figure 77. GCC Countries PPARδ Agonist Revenue Growth 2020-2025 ($ millions) Figure 78. Manufacturing Cost Structure Analysis of PPARδ Agonist in 2025 Figure 79. Manufacturing Process Analysis of PPARδ Agonist Figure 80. Industry Chain Structure of PPARδ Agonist Figure 81. Channels of Distribution Figure 82. Global PPARδ Agonist Sales Market Forecast by Region (2026-2031) Figure 83. Global PPARδ Agonist Revenue Market Share Forecast by Region (2026-2031) Figure 84. Global PPARδ Agonist Sales Market Share Forecast by Type (2026-2031) Figure 85. Global PPARδ Agonist Revenue Market Share Forecast by Type (2026-2031) Figure 86. Global PPARδ Agonist Sales Market Share Forecast by Application (2026-2031) Figure 87. Global PPARδ Agonist Revenue Market Share Forecast by Application (2026-2031)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AbMole|||Delta Bio|||Inventiva|||RECHEM|||DMK